Fat removal techniques, such as liposuction, are successful in sculpting problem areas and producing a slender silhouette. However, patients who have poor skin elasticity may not achieve their desired results with traditional liposuction surgery. Dr. Hotchandani recognized this dilemma and has trademarked ReNUplasty® liposuction technique to deliver superior contouring results. This innovative approach combines VASERlipo® with Renuvion™, tightening the skin while removing unwanted fatty tissue in one procedure.
Men and women who are considering ReNUplasty® must be at or close to a healthy weight and have realistic expectations of their results. Additionally, ideal candidates for this procedure also have poor skin elasticity in the target areas. You may be a candidate for ReNUplasty® treatment if you have excess body fat and skin laxity but have difficulty achieving the figure you want. Dr. Hotchandani will determine if ReNUplasty® is right for you during the initial consultation.
ReNUplasty® is Dr. Hotchandani’s trademarked body contouring surgery that incorporates two highly effective techniques: VASERlipo® and Renuvion™. The powerful combination of these technologies gives patients with skin laxity and stubborn fat deposits the physique of their dreams.
VASERlipo® involves the use of traditional tumescent liposuction with the assistance of ultrasound technology. Ultrasound energy is delivered to the targeted fat with a thin probe that is inserted through small incisions at the treatment site. This process helps break down fat cells for easier and faster removal using a suction cannula.
Renuvion™ is revolutionizing the aesthetic industry by delivering both cold helium plasma and radiofrequency (RF) energy to precisely tighten lax tissue. As the fat cells disrupted by VASERlipo® are removed using a cannula, the Renuvion™ device works to contract the skin in the treatment area. This technique defines the newly formed contour while making the surface smoother and more youthful.
*Results and patient experience may vary.